2-Amino-9-[(2,3,5-tri-O-benzoyl-2-C-Methyl-β-D-ribofuranosyl)]-9H-purine structure
|
Common Name | 2-Amino-9-[(2,3,5-tri-O-benzoyl-2-C-Methyl-β-D-ribofuranosyl)]-9H-purine | ||
|---|---|---|---|---|
| CAS Number | 1345969-99-4 | Molecular Weight | 593.59 | |
| Density | 1.4±0.1 g/cm3 | Boiling Point | 797.7±70.0 °C at 760 mmHg | |
| Molecular Formula | C32H27N5O7 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 436.2±35.7 °C | |
Use of 2-Amino-9-[(2,3,5-tri-O-benzoyl-2-C-Methyl-β-D-ribofuranosyl)]-9H-purine9-(2,3,5-Tri-O-benzoyl-2-C-methyl-β-D-ribofuranosyl)-9H-purin-2-amine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 9-(2,3,5-Tri-O-benzoyl-2-C-methyl-β-D-ribofuranosyl)-9H-purin-2-amine |
|---|---|
| Synonym | More Synonyms |
| Description | 9-(2,3,5-Tri-O-benzoyl-2-C-methyl-β-D-ribofuranosyl)-9H-purin-2-amine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 797.7±70.0 °C at 760 mmHg |
| Molecular Formula | C32H27N5O7 |
| Molecular Weight | 593.59 |
| Flash Point | 436.2±35.7 °C |
| Exact Mass | 593.191040 |
| LogP | 7.04 |
| Vapour Pressure | 0.0±2.8 mmHg at 25°C |
| Index of Refraction | 1.678 |
| 9H-Purin-2-amine, 9-(2,3,5-tri-O-benzoyl-2-C-methyl-β-D-ribofuranosyl)- |
| MFCD25542505 |
| 9-(2,3,5-Tri-O-benzoyl-2-C-methyl-β-D-ribofuranosyl)-9H-purin-2-amine |